Hosking Partners LLP Bristol Myers Squibb CO Transaction History

Hosking Partners LLP

  • $2.61 Billion
  • Q2 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023
BUY
$63.71 - $70.74 $185,332 - $205,782
2,909 Added 7.34%
42,550 $2.72 Million
Q1 2023

May 09, 2023
SELL
$65.71 - $74.53 $492,036 - $558,080
-7,488 Reduced 15.89%
39,641 $2.75 Million
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $3.78 Million - $4.47 Million
-55,148 Reduced 53.92%
47,129 $3.39 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $968 - $572,458
-7,450 Reduced 6.79%
102,277 $7.27 Million
Q2 2022

Aug 04, 2022
SELL
$72.62 - $79.98 $1.5 Million - $1.65 Million
-20,692 Reduced 15.87%
109,727 $8.45 Million
Q1 2022

May 05, 2022
SELL
$61.48 - $73.72 $170,791 - $204,794
-2,778 Reduced 2.09%
130,419 $9.52 Million
Q4 2021

Feb 04, 2022
SELL
$53.63 - $62.52 $135,147 - $157,550
-2,520 Reduced 1.86%
133,197 $8.31 Million
Q3 2021

Nov 09, 2021
SELL
$59.17 - $69.31 $882,993 - $1.03 Million
-14,923 Reduced 9.91%
135,717 $8.03 Million
Q2 2021

Aug 03, 2021
SELL
$61.91 - $67.42 $129,020 - $140,503
-2,084 Reduced 1.36%
150,640 $10.1 Million
Q1 2021

May 10, 2021
SELL
$59.34 - $66.74 $338,059 - $380,217
-5,697 Reduced 3.6%
152,724 $9.64 Million
Q4 2020

Feb 05, 2021
SELL
$57.74 - $65.43 $305,964 - $346,713
-5,299 Reduced 3.24%
158,421 $9.83 Million
Q3 2020

Nov 09, 2020
SELL
$57.43 - $63.64 $318,047 - $352,438
-5,538 Reduced 3.27%
163,720 $9.87 Million
Q2 2020

Aug 05, 2020
SELL
$54.82 - $64.09 $653,070 - $763,504
-11,913 Reduced 6.58%
169,258 $9.95 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $244,992 - $356,030
-5,280 Reduced 2.83%
181,171 $10.1 Million
Q4 2019

Feb 06, 2020
SELL
$49.21 - $64.19 $323,162 - $421,535
-6,567 Reduced 3.4%
186,451 $12 Million
Q3 2019

Nov 13, 2019
SELL
$42.77 - $50.71 $388,308 - $460,396
-9,079 Reduced 4.49%
193,018 $9.79 Million
Q2 2019

Aug 13, 2019
SELL
$44.62 - $49.34 $38,551 - $42,629
-864 Reduced 0.43%
202,097 $9.17 Million
Q1 2019

May 08, 2019
SELL
$45.12 - $53.8 $46,924 - $55,952
-1,040 Reduced 0.51%
202,961 $9.68 Million
Q4 2018

Feb 11, 2019
SELL
$48.76 - $63.23 $368,869 - $478,334
-7,565 Reduced 3.58%
204,001 $10.6 Million
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $342,840 - $386,697
-6,212 Reduced 2.85%
211,566 $13.1 Million
Q2 2018

Aug 13, 2018
BUY
$50.53 - $62.98 $79,635 - $99,256
1,576 Added 0.73%
217,778 $12.1 Million
Q1 2018

May 10, 2018
BUY
$59.92 - $68.98 $553,840 - $637,582
9,243 Added 4.47%
216,202 $13.7 Million
Q4 2017

Feb 08, 2018
BUY
$59.94 - $65.35 $865,533 - $943,653
14,440 Added 7.5%
206,959 $12.7 Million
Q3 2017

Nov 09, 2017
BUY
$55.23 - $63.74 $32,640 - $37,670
591 Added 0.31%
192,519 $12.3 Million
Q2 2017

Aug 09, 2017
BUY
N/A
191,928
191,928 $10.7 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hosking Partners LLP Portfolio

Follow Hosking Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hosking Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Hosking Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email